reports
- GlobalData Healthcare Department
Chembio Diagnostic, Inc. (CEMI) - Financial and Strategic SWOT Analysi...
Chembio Diagnostic, Inc. (CEMI) - Financial and Strategic SWOT Analysis Review Summary Chembio Diagnostic, Inc. (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP), which makes POC testing faster. Its DPP technology is used to treat infectious diseases such as HIV, Ebola, syphilis, Zika, malaria ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.